Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

236.66 -11.12 (-4.49%)

Official Closing Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action

May 12, 2025

From Law Offices of Howard G. Smith

Via Business Wire

WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs

May 12, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year...

Via StockStory

Topics World Trade

WST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

May 11, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

May 09, 2025

From Pomerantz LLP

Via GlobeNewswire

3 Healthcare Stocks in Hot Water

May 09, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Economy Stocks

WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm

May 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

May 08, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

May 08, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

May 07, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Long-Term Shareholder Alert: If You Hold AppLovin Corporation (NASDAQ: APP); Maison Solutions, Inc. (NASDAQ: MSS); Monolithic Power Systems, Inc. (NASDAQ: MPWR); or West Pharmaceutical Services, Inc. (NYSE: WST), Contact Grabar Law Office Today

May 07, 2025

From Grabar Law Office

Via GlobeNewswire

WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

May 07, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 06, 2025

From The Schall Law Firm

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services

May 06, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives

May 05, 2025

From Labaton Keller Sucharow LLP

Via Business Wire

1 Cash-Heavy Stock Worth Your Attention and 2 to Think Twice About

May 02, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Topics Economy

3 Mid-Cap Stocks Facing Headwinds

April 29, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

Topics Economy

3 Dawdling Stocks Facing Headwinds

April 28, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

Topics Economy

Repligen (RGEN) Q1 Earnings: What To Expect

April 28, 2025

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what to look for.

Via StockStory

Topics World Trade

West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag ↗

April 24, 2025

West Pharmaceutical topped Q1 estimates and raised 2025 guidance, citing stronger device demand and improved inventory trends across key markets.

Via Benzinga

These S&P500 stocks are gapping in today's session ↗

April 24, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Via Chartmill

West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars

April 24, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year...

Via StockStory

Topics Economy

Insights Ahead: West Pharmaceutical Servs's Quarterly Earnings ↗

April 23, 2025

Via Benzinga

Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗

April 24, 2025

U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...

Via Benzinga

Topics Government World Trade

West Pharmaceutical Services Earnings: What To Look For From WST

April 23, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

These S&P500 stocks are moving in today's session ↗

April 21, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

April 17, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

April 17, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Top S&P500 movers in Thursday's pre-market session ↗

April 17, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

April 09, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.